It is necessary to examine the characteristics of the dissemination nodules to establish a therapeutic strategy for peritoneal dissemination from digestive malignancy. Ki-67 expression as a proliferation marker in peritoneal dissemination nodules was investigated. The subjects were 15 patients with gastrointestinal cancers who underwent resection of the primary tumor and disseminated nodules. The expression of Ki-67 in both primary tumor and peritoneal dissemination nodule from each patient was evaluated by immunohistochemistry. Ki-67 labeling index in the original tumorwas higher than that in the disseminated nodule in 13 of 15 patients (P < 0.0001). The mean value of Ki-67 labeling index was 42.2% in the 15 original tumors and 18.7% in the 15 disseminated nodules. Proliferative activity in the disseminated nodules was lower than that in the primary tumors. Further examination about characteristics of cancer dissemination is needed to treat patients with peritoneal metastasis.
CITATION STYLE
Yamauchi, H., Suto, T., Kigure, W., Morita, H., Kato, T., Yajima, R., … Kuwano, H. (2011). The progression potential of peritoneal dissemination nodules from gastrointestinal tumors. International Surgery, 96(4), 352–357. https://doi.org/10.9738/CC21.1
Mendeley helps you to discover research relevant for your work.